AbbVie (ABBV) Shares Repurchased (2013 - 2026)

AbbVie (ABBV) has 14 years of Shares Repurchased data on file, last reported at $1.5 billion in Q1 2026.

• Shares Repurchased for Q1 2026 came in at $1.5 billion, up 54.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 12.12% YoY), and the FY2025 annual result was $980.0 million, down 42.62% from the prior year.
• Shares Repurchased grew to $1.5 billion in Q1 2026 per ABBV's latest filing, from $3.0 million in the prior quarter.
• Over five years, Shares Repurchased peaked at $2.0 billion in Q1 2023 and troughed at $3.0 million in Q4 2023.
• A 5-year average of $449.2 million and a median of $10.0 million in 2023 frame the typical range for Shares Repurchased.
• The sharpest annual moves came in 2024 and 2025: Shares Repurchased surged 11833.33% in 2024, then tumbled 99.16% in 2025.
• A 5-year view of Shares Repurchased shows it stood at $4.0 million in 2022, then fell by 25.0% to $3.0 million in 2023, then surged by 11833.33% to $358.0 million in 2024, then plunged by 99.16% to $3.0 million in 2025, then surged by 49533.33% to $1.5 billion in 2026.
• Business Quant data shows ABBV's Shares Repurchased at $1.5 billion in Q1 2026, $3.0 million in Q4 2025, and $4.0 million in Q3 2025.